Can visual interpretation of NucliSens graphs reduce the need for repeat viral load testing?
- PMID: 31747448
- PMCID: PMC6867593
- DOI: 10.1371/journal.pone.0223597
Can visual interpretation of NucliSens graphs reduce the need for repeat viral load testing?
Abstract
Background: In Zimbabwe, viral load (VL) testing for people living with HIV on antiretroviral therapy is performed at the National Microbiology Reference Laboratory using a NucliSens machine. Anecdotal evidence has shown that invalid graphs for "Target Not Detectable (TND)" will upon repeat VL testing produce a valid result for virus not detected, therefore removing the need to repeat the test. This needs formal assessment.
Objectives: To determine i) intra- and inter-rater agreement of the visual interpretation of NucliSens graphs (Target Detectable [TD], TND and No Line [NL]) between two laboratory scientists and ii) sensitivity, specificity and predictive values of the NucliSens graphs compared with repeat VL results.
Method: Cross sectional study using secondary data. Two laboratory scientists independently rated graphs one week apart for intra-rater agreement and compared final ratings with each other for inter-rater agreement. Consensus interpretations of graphs were compared with repeat VL results. Kappa coefficients were used to obtain measures of agreement.
Results: There were 562 patients with NucliSens graphs and repeat VL. Kappa scores were: 0.98 (Scientist A); 0.99 (Scientist B); 0.96 (Scientist A versus Scientist B); and 0.65 (NucliSens graphs versus VL). Sensitivity, specificity, positive predictive value and negative predictive value for graphs compared with VL were 71%, 92%, 79% and 89% respectively.
Conclusion: Intra-and inter-rater agreements were almost perfect. The negative predictive value translates to a false negative rate of 11%. If repeat VL testing is not done, the clinical consequences need to be balanced against cost savings and the risks outweigh the benefits.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Early diagnosis of human immunodeficiency virus-1 infection in infants with the NucliSens EasyQ assay on dried blood spots.J Clin Virol. 2010 May;48(1):40-3. doi: 10.1016/j.jcv.2010.02.006. Epub 2010 Mar 7. J Clin Virol. 2010. PMID: 20211580
-
Finger Prick Dried Blood Spots for HIV Viral Load Measurement in Field Conditions in Zimbabwe.PLoS One. 2015 May 22;10(5):e0126878. doi: 10.1371/journal.pone.0126878. eCollection 2015. PLoS One. 2015. PMID: 26001044 Free PMC article.
-
Validation of the Viral Load Testing Criteria - an algorithm for targeted viral load testing in HIV-positive adults receiving antiretroviral therapy.Trop Med Int Health. 2019 Mar;24(3):356-362. doi: 10.1111/tmi.13201. Epub 2019 Jan 24. Trop Med Int Health. 2019. PMID: 30624826
-
Multi-site clinical evaluation of the Xpert(®) HIV-1 viral load assay.J Clin Virol. 2016 Jul;80:27-32. doi: 10.1016/j.jcv.2016.04.014. Epub 2016 Apr 26. J Clin Virol. 2016. PMID: 27135387
-
Performance of the Xpert HIV-1 Viral Load Assay: a Systematic Review and Meta-analysis.J Clin Microbiol. 2018 Mar 26;56(4):e01673-17. doi: 10.1128/JCM.01673-17. Print 2018 Apr. J Clin Microbiol. 2018. PMID: 29386266 Free PMC article.
References
-
- World Health Organization. WHO HIV Update. July 2018.
-
- Columbia University. Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) 2015–2016. Available at: http://phia.icap.columbia.edu/wp-content/uploads/2016/11/ZIMBABWE-Factsh... (accessed 18 April 2018)
-
- World Health Organization; Scaling up antiretroviral therapy in resource-limited settings: Guidelines for a public health approach. 2003 revision. WHO, Geneva, Switzerland.
-
- Harries AD, Zachariah R, van Oosterhout JJ, Reid SD, Hosseinipour MC, Arendt V et al. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis 2010; 10: 60–65. 10.1016/S1473-3099(09)70321-4 - DOI - PubMed
-
- World Health Organization; Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. June 2013. WHO, Geneva, Switzerland. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical